CRMD
CorMedix Inc
Halal Rating :
Last Price
$12.19
Last updated:
Market Cap
-
7D Change
9.62%
1 Year Change
271.65%
Company Overview
Industries
Exchange
Next Earnings Date
CorMedix Inc. is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases. Their lead product candidate is DefenCath™, an antimicrobial and antifungal solution designed to prevent catheter-related bloodstream infections (CRBSIs) in patients with end-stage renal disease receiving hemodialysis through central venous catheters.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $11.46m | $14.75m | - | $10007.0 | 0.00% | 0.07% |
| June 30, 2024 | $1.31m | $16.11m | - | $6556.0 | 0.00% | 0.04% |
Company Impact
Help us evaluate CorMedix Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.